Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Treatment of eosinophilic esophagitis with diets: an update.

Lucendo AJ, Molina-Infante J.

Minerva Gastroenterol Dietol. 2019 Nov 20. doi: 10.23736/S1121-421X.19.02634-5. [Epub ahead of print]

PMID:
31760737
2.

Genetic predictors of long-term response and trough levels of infliximab in crohn's disease.

Salvador-Martín S, López-Cauce B, Nuñez O, Laserna-Mendieta EJ, García MI, Lobato E, Abarca-Zabalía J, Sanjurjo-Saez M, Lucendo AJ, Marín-Jiménez I, Menchén LA, López-Fernández LA.

Pharmacol Res. 2019 Nov;149:104478. doi: 10.1016/j.phrs.2019.104478. Epub 2019 Oct 9. Review.

PMID:
31605784
3.

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

Casanova MJ, Chaparro M, Mínguez M, Ricart E, Taxonera C, García-López S, Guardiola J, López-San Román A, Iglesias E, Beltrán B, Sicilia B, Vera MI, Hinojosa J, Riestra S, Domènech E, Calvet X, Pérez-Calle JL, Martín-Arranz MD, Aldeguer X, Rivero M, Monfort D, Barrio J, Esteve M, Márquez L, Lorente R, García-Planella E, de Castro L, Bermejo F, Merino O, Rodríguez-Pérez A, Martínez-Montiel P, Van Domselaar M, Alcaín G, Domínguez-Cajal M, Muñoz C, Gomollón F, Fernández-Salazar L, García-Sepulcre MF, Rodríguez-Lago I, Gutiérrez A, Argüelles-Arias F, Rodriguez C, Rodríguez GE, Bujanda L, Llaó J, Varela P, Ramos L, Huguet JM, Almela P, Romero P, Navarro-Llavat M, Abad Á, Ramírez-de la Piscina P, Lucendo AJ, Sesé E, Madrigal RE, Charro M, García-Herola A, Pajares R, Khorrami S, Gisbert JP.

Inflamm Bowel Dis. 2019 Aug 29. pii: izz192. doi: 10.1093/ibd/izz192. [Epub ahead of print]

PMID:
31504569
4.

Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits.

Laserna-Mendieta EJ, Salvador-Martín S, Arias-González L, Ruiz-Ponce M, Menchén LA, Sánchez C, López-Fernández LA, Lucendo AJ.

Clin Chem Lab Med. 2019 Nov 26;57(12):1906-1914. doi: 10.1515/cclm-2019-0202.

PMID:
31085742
5.

Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.

Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J, Hartmann D, Bredenoord AJ, Ciriza de Los Rios C, Schubert S, Brückner S, Madisch A, Hayat J, Tack J, Attwood S, Mueller R, Greinwald R, Schoepfer A, Straumann A; International EOS-1 Study Group.

Gastroenterology. 2019 Jul;157(1):74-86.e15. doi: 10.1053/j.gastro.2019.03.025. Epub 2019 Mar 26.

6.

Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies.

Navarro P, Arias Á, Arias-González L, Laserna-Mendieta EJ, Ruiz-Ponce M, Lucendo AJ.

Aliment Pharmacol Ther. 2019 May;49(9):1116-1125. doi: 10.1111/apt.15231. Epub 2019 Mar 18. Review.

PMID:
30887555
7.

Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.

Arias Á, Lucendo AJ.

Expert Rev Gastroenterol Hepatol. 2019 Feb;13(2):99-117. doi: 10.1080/17474124.2019.1546120. Epub 2018 Nov 15. Review.

PMID:
30791784
8.

Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations.

Laserna-Mendieta EJ, Lucendo AJ.

Clin Chem Lab Med. 2019 Aug 27;57(9):1295-1307. doi: 10.1515/cclm-2018-1063. Review.

PMID:
30785706
9.

Eosinophilic esophagitis: An evidenced-based approach to diagnosis and treatment.

Pérez-Martínez I, Rodrigo L, Lucendo AJ.

Med Clin (Barc). 2019 Jun 7;152(11):444-449. doi: 10.1016/j.medcli.2018.10.022. Epub 2018 Dec 3. Review. English, Spanish.

PMID:
30522813
10.

Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease.

Verdejo C, Hervías D, Roncero Ó, Arias Á, Bouhmidi A, Lorente R, Salueña I, Lucendo AJ.

Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1521-1527. doi: 10.1097/MEG.0000000000001284.

PMID:
30303822
11.

Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.

Chaparro M, Garre A, Ricart E, Iborra M, Mesonero F, Vera I, Riestra S, García-Sánchez V, Luisa De Castro M, Martin-Cardona A, Aldeguer X, Mínguez M, de-Acosta MB, Rivero M, Muñoz F, Andreu M, Bargalló A, González-Muñoza C, Pérez Calle JL, García-Sepulcre MF, Bermejo F, Huguet JM, Cabriada JL, Gutiérrez A, Mañosa M, Villoria A, Carbajo AY, Lorente R, García-López S, Piqueras M, Hinojosa E, Arajol C, Sicilia B, Conesa AM, Sainz E, Almela P, Llaó J, Roncero O, Camo P, Taxonera C, Domselaar MV, Pajares R, Legido J, Madrigal R, Lucendo AJ, Alcaín G, Doménech E, Gisbert JP; GETECCU study group.

Aliment Pharmacol Ther. 2018 Oct;48(8):839-851. doi: 10.1111/apt.14930.

PMID:
30281832
12.

Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.

McNicholl AG, Molina-Infante J, Lucendo AJ, Calleja JL, Pérez-Aisa Á, Modolell I, Aldeguer X, Calafat M, Comino L, Ramas M, Callejo Á, Badiola C, Serra J, Gisbert JP.

Helicobacter. 2018 Oct;23(5):e12529. doi: 10.1111/hel.12529. Epub 2018 Aug 23.

PMID:
30141228
13.

Incidence and prevalence of eosinophilic oesophagitis increase continiously in adults and children in Central Spain: A 12-year population-based study.

Arias Á, Lucendo AJ.

Dig Liver Dis. 2019 Jan;51(1):55-62. doi: 10.1016/j.dld.2018.07.016. Epub 2018 Jul 31.

PMID:
30115573
14.

Health-related quality of life in diabetes mellitus and its social, demographic and clinical determinants: A nationwide cross-sectional survey.

Rodríguez-Almagro J, García-Manzanares Á, Lucendo AJ, Hernández-Martínez A.

J Clin Nurs. 2018 Nov;27(21-22):4212-4223. doi: 10.1111/jocn.14624. Epub 2018 Jul 27.

PMID:
29987853
15.

Esophageal dilation in eosinophilic esophagitis: risks, benefits, and when to do it.

Lucendo AJ, Molina-Infante J.

Curr Opin Gastroenterol. 2018 Jul;34(4):226-232. doi: 10.1097/MOG.0000000000000442. Review.

PMID:
29846259
16.

Genetic variations in the TLR3 locus are associated with eosinophilic esophagitis.

Ávila-Castellano R, García-Lozano JR, Cimbollek S, Lucendo AJ, Bozada JM, Quiralte J.

United European Gastroenterol J. 2018 Apr;6(3):349-357. doi: 10.1177/2050640617732643. Epub 2017 Sep 13.

17.

Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis.

Arias Á, Vicario M, Bernardo D, Olalla JM, Fortea M, Montalban-Arques A, Martínez-Fernández P, González-Castro AM, Mota-Huertas T, Arias-González L, Lucendo AJ.

Clin Transl Gastroenterol. 2018 Apr 25;9(4):147. doi: 10.1038/s41424-018-0017-4.

18.

Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.

Munoz-Persy M, Lucendo AJ.

Eur J Pediatr. 2018 May;177(5):649-663. doi: 10.1007/s00431-018-3129-7. Epub 2018 Mar 17. Review.

PMID:
29549437
19.

Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study.

Molina-Infante J, Gutierrez-Junquera C, Savarino E, Penagini R, Modolell I, Bartolo O, Prieto-García A, Mauro A, Alcedo J, Perelló A, Guarner-Argente C, Alcaide N, Vegas AM, Barros-García P, Murzi-Pulgar M, Perona M, Gisbert JP, Lucendo AJ; Upper GI Tract Study Group from the Spanish Gastroenterological Association (AEG).

Am J Gastroenterol. 2018 Jul;113(7):972-979. doi: 10.1038/s41395-018-0035-6. Epub 2018 Mar 15.

PMID:
29545632
20.

Dietary therapy for eosinophilic esophagitis.

Molina-Infante J, Lucendo AJ.

J Allergy Clin Immunol. 2018 Jul;142(1):41-47. doi: 10.1016/j.jaci.2018.02.028. Epub 2018 Mar 6. Review.

PMID:
29522850
21.

Clinical guidelines for endoscopic mucosal resection of non-pedunculated colorectal lesions.

Albéniz E, Pellisé M, Gimeno García AZ, Lucendo AJ, Alonso Aguirre PA, Herreros de Tejada A, Álvarez MA, Fraile M, Herráiz Bayod M, López Rosés L, Martínez Ares D, Ono A, Parra Blanco A, Redondo E, Sánchez Yagüe A, Soto S, Díaz Tasende J, Montes Díaz M, Téllez MR, García O, Zuñiga Ripa A, Hernández Conde M, Alberca de Las Parras F, Gargallo C, Saperas E, Navas MM, Gordillo J, Ramos Zabala F, Echevarría JM, Bustamante M, González Haba M, González Huix F, González Suárez B, Vila Costas JJ, Guarner Argente C, Múgica F, Cobián J, Rodríguez Sánchez J, López Viedma B, Pin N, Marín Gabriel JC, Nogales Ó, de la Peña J, Navajas León FJ, León Brito H, Remedios D, Esteban JM, Barquero D, Martínez Cara JG, Martínez Alcalá F, Fernández Urién I, Valdivielso E; en nombre del Grupo Español de Resección Endoscópica de la Sociedad Española de Endoscopia Digestiva.

Gastroenterol Hepatol. 2018 Mar;41(3):175-190. doi: 10.1016/j.gastrohep.2017.08.013. Epub 2018 Feb 12. English, Spanish.

PMID:
29449039
22.

Determinant factors of quality of life in adult patients with eosinophilic esophagitis.

Lucendo AJ, Arias-González L, Molina-Infante J, Arias Á.

United European Gastroenterol J. 2018 Feb;6(1):38-45. doi: 10.1177/2050640617707095. Epub 2017 Apr 21.

23.

Rising incidence and prevalence of adult eosinophilic esophagitis in midwestern Spain (2007-2016).

Molina-Infante J, Gonzalez-Cordero PL, Ferreira-Nossa HC, Mata-Romero P, Lucendo AJ, Arias A.

United European Gastroenterol J. 2018 Feb;6(1):29-37. doi: 10.1177/2050640617705913. Epub 2017 Apr 21.

24.

Eosinophilic oesophagitis: Current evidence-based diagnosis and treatment.

Lucendo AJ, Molina-Infante J.

Gastroenterol Hepatol. 2018 Apr;41(4):281-291. doi: 10.1016/j.gastrohep.2017.12.007. Epub 2018 Feb 13. Review. English, Spanish.

PMID:
29422238
25.

Clinical guidelines for endoscopic mucosal resection of non-pedunculated colorectal lesions.

Albéniz E, Pellisé M, Gimeno-García AZ, Lucendo AJ, Alonso-Aguirre PA, Herreros de Tejada A, Álvarez MA, Fraile M, Herráiz Bayod M, López Rosés L, Martínez Ares D, Ono A, Parra Blanco A, Redondo E, Sánchez-Yagüe A, Soto S, Díaz-Tasende J, Montes Díaz M, Rodríguez-Téllez M, García O, Zuñiga Ripa A, Hernández Conde M, Alberca de Las Parras F, Gargallo CJ, Saperas E, Muñoz Navas M, Gordillo J, Ramos Zabala F, Echevarría JM, Bustamante M, González-Haba M, González-Huix F, González-Suárez B, Vila Costas JJ, Guarner Argente C, Múgica F, Cobián J, Rodríguez Sánchez J, López Viedma B, Pin N, Marín Gabriel JC, Nogales Ó, de la Peña J, Navajas León FJ, León Brito H, Remedios D, Esteban JM, Barquero D, Martínez Cara JG, Martínez Alcalá F, Fernández-Urién I, Valdivielso E.

Rev Esp Enferm Dig. 2018 Mar;110(3):179-194. doi: 10.17235/reed.2018.5086/2017. Review.

26.

Capsule endoscopy in young patients with iron deficiency anaemia and negative bidirectional gastrointestinal endoscopy.

Yung DE, Rondonotti E, Giannakou A, Avni T, Rosa B, Toth E, Lucendo AJ, Sidhu R, Beaumont H, Ellul P, Negreanu L, Jiménez-Garcia VA, McNamara D, Kopylov U, Elli L, Triantafyllou K, Shibli F, Riccioni ME, Bruno M, Dray X, Plevris JN, Koulaouzidis A; And the Capsule Endoscopy in Young Patients with IDA research group, Argüelles-Arias F, Becq A, Branchi F, Tejero-Bustos MÁ, Cotter J, Eliakim R, Ferretti F, Gralnek IM, Herrerias-Gutierrez JM, Hussey M, Jacobs M, Johansson GW, McAlindon M, Montiero S, Nemeth A, Pennazio M, Rattehalli D, Stemate A, Tortora A, Tziatzios G.

United European Gastroenterol J. 2017 Nov;5(7):974-981. doi: 10.1177/2050640617692501. Epub 2017 Feb 1.

27.

Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: A Paradigm Shift.

Molina-Infante J, Lucendo AJ.

Am J Gastroenterol. 2017 Dec;112(12):1770-1773. doi: 10.1038/ajg.2017.404. Epub 2017 Oct 31. No abstract available.

PMID:
29087399
28.

Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study.

Molina-Infante J, Arias Á, Alcedo J, Garcia-Romero R, Casabona-Frances S, Prieto-Garcia A, Modolell I, Gonzalez-Cordero PL, Perez-Martinez I, Martin-Lorente JL, Guarner-Argente C, Masiques ML, Vila-Miravet V, Garcia-Puig R, Savarino E, Sanchez-Vegazo CT, Santander C, Lucendo AJ.

J Allergy Clin Immunol. 2018 Apr;141(4):1365-1372. doi: 10.1016/j.jaci.2017.08.038. Epub 2017 Oct 23.

PMID:
29074457
29.

Eosinophilic esophagitis: What can we learn from Crohn's disease?

Molina-Infante J, Schoepfer AM, Lucendo AJ, Dellon ES.

United European Gastroenterol J. 2017 Oct;5(6):762-772. doi: 10.1177/2050640616672953. Epub 2016 Sep 29. Review.

30.

Eosinophilic esophagitis: current evidence-based diagnosis and treatment in children and adults.

Lucendo AJ.

Minerva Gastroenterol Dietol. 2018 Mar;64(1):62-74. doi: 10.23736/S1121-421X.17.02437-0. Epub 2017 Sep 11. Review.

PMID:
28895370
31.

The role of endoscopy in eosinophilic esophagitis: from diagnosis to therapy.

Lucendo AJ, Arias Á, Molina-Infante J, Arias-González L.

Expert Rev Gastroenterol Hepatol. 2017 Dec;11(12):1135-1149. doi: 10.1080/17474124.2017.1367664. Epub 2017 Aug 17. Review.

PMID:
28803528
32.

Editorial: oesophageal dilation in eosinophilic oesophagitis-can and should, but when and how? Authors' reply.

Moawad FJ, Lucendo AJ, Molina-Infante J.

Aliment Pharmacol Ther. 2017 Sep;46(5):558. doi: 10.1111/apt.14233. No abstract available.

33.

Systematic review: health-related quality of life in children and adults with eosinophilic oesophagitis-instruments for measurement and determinant factors.

Lucendo AJ, Arias-González L, Molina-Infante J, Arias Á.

Aliment Pharmacol Ther. 2017 Aug;46(4):401-409. doi: 10.1111/apt.14194. Epub 2017 Jun 22. Review.

34.

Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis.

Moawad FJ, Molina-Infante J, Lucendo AJ, Cantrell SE, Tmanova L, Douglas KM.

Aliment Pharmacol Ther. 2017 Jul;46(2):96-105. doi: 10.1111/apt.14123. Epub 2017 May 17. Review.

35.

Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, Amil Dias J, Bove M, González-Cervera J, Larsson H, Miehlke S, Papadopoulou A, Rodríguez-Sánchez J, Ravelli A, Ronkainen J, Santander C, Schoepfer AM, Storr MA, Terreehorst I, Straumann A, Attwood SE.

United European Gastroenterol J. 2017 Apr;5(3):335-358. doi: 10.1177/2050640616689525. Epub 2017 Jan 23. Review.

36.

Macroscopic findings in collagenous colitis: a multi-center, retrospective, observational cohort study.

Koulaouzidis A, Yung DE, Nemeth A, Sjöberg K, Giannakou A, Qureshi R, Bartzis L, McNeill M, Johansson GW, Lucendo AJ, Fineron P, Trimble KC, Saeed A, Plevris JN, Toth E.

Ann Gastroenterol. 2017;30(3):309-314. doi: 10.20524/aog.2017.0131. Epub 2017 Feb 20.

37.

Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment.

Fernandez-Bañares F, Piqueras M, Guagnozzi D, Robles V, Ruiz-Cerulla A, Casanova MJ, Gisbert JP, Busquets D, Arguedas Y, Pérez-Aisa A, Fernández-Salazar L, Lucendo AJ; GECM (Grupo Español de Colitis Microscópica).

Dig Liver Dis. 2017 Sep;49(9):973-977. doi: 10.1016/j.dld.2017.03.026. Epub 2017 Apr 10.

PMID:
28457904
38.

Proton pump inhibitor-responsive esophageal eosinophilia: still a valid diagnosis?

Molina-Infante J, Gonzalez-Cordero PL, Lucendo AJ.

Curr Opin Gastroenterol. 2017 Jul;33(4):285-292. doi: 10.1097/MOG.0000000000000371. Review.

PMID:
28445189
39.

Validity and Reliability of Administrative Coded Data for the Identification of Hospital-Acquired Infections: An Updated Systematic Review with Meta-Analysis and Meta-Regression Analysis.

Redondo-González O, Tenías JM, Arias Á, Lucendo AJ.

Health Serv Res. 2018 Jun;53(3):1919-1956. doi: 10.1111/1475-6773.12691. Epub 2017 Apr 11.

40.

Association between atopic manifestations and eosinophilic esophagitis: A systematic review and meta-analysis.

González-Cervera J, Arias Á, Redondo-González O, Cano-Mollinedo MM, Terreehorst I, Lucendo AJ.

Ann Allergy Asthma Immunol. 2017 May;118(5):582-590.e2. doi: 10.1016/j.anai.2017.02.006. Epub 2017 Mar 30. Review.

PMID:
28366582
41.

Quality assessment of clinical practice guidelines for eosinophilic esophagitis using the AGREE II instrument.

Lucendo AJ, Arias Á, Redondo-González O, Molina-Infante J.

Expert Rev Gastroenterol Hepatol. 2017 Apr;11(4):383-390. doi: 10.1080/17474124.2017.1285696. Epub 2017 Feb 1. Review.

PMID:
28117605
42.

Drug Exposure and the Risk of Microscopic Colitis: A Critical Update.

Lucendo AJ.

Drugs R D. 2017 Mar;17(1):79-89. doi: 10.1007/s40268-016-0171-7. Review.

43.

Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients.

Lucendo AJ, Arias Á, Roncero Ó, Hervías D, Verdejo C, Naveas-Polo C, Bouhmidi A, Lorente R, Alcázar LM, Salueña I, García-Quiñones JA, Carrillo-Ramos MJ.

Dig Liver Dis. 2017 Apr;49(4):405-411. doi: 10.1016/j.dld.2016.12.005. Epub 2016 Dec 14.

PMID:
28096058
44.

Update on dietary therapy for eosinophilic esophagitis in children and adults.

Molina-Infante J, Gonzalez-Cordero PL, Arias A, Lucendo AJ.

Expert Rev Gastroenterol Hepatol. 2017 Feb;11(2):115-123. doi: 10.1080/17474124.2017.1271324. Epub 2016 Dec 23. Review.

PMID:
27998193
45.

Seasonal Variation in the Diagnosis of Eosinophilic Esophagitis: There and Back Again.

Lucendo AJ, Molina-Infante J, Arias Á, González-Cervera J.

J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):e25. doi: 10.1097/MPG.0000000000001417. No abstract available.

PMID:
27642782
46.

Letter: dietary therapy in eosinophilic oesophagitis - do not test, just eliminate and reintroduce the most common food triggers.

Molina-Infante J, Lucendo AJ.

Aliment Pharmacol Ther. 2016 Oct;44(8):904-5. doi: 10.1111/apt.13742. No abstract available.

47.

The Use of the Fracture Risk Assessment (FRAX®) Tool in Predicting Risk of Fractures in Patients With Inflammatory Bowel Disease: A Systematic Review.

Serrano-Montalbán B, Arias Á, Friginal-Ruiz AB, Lucendo AJ.

J Clin Densitom. 2017 Apr - Jun;20(2):180-187. doi: 10.1016/j.jocd.2016.08.010. Epub 2016 Sep 7. Review.

PMID:
27614421
48.

Response to Ishimura et al.

Molina-Infante J, Lucendo AJ, Zamorano J.

Am J Gastroenterol. 2016 Aug;111(8):1204-5. doi: 10.1038/ajg.2016.218. No abstract available.

PMID:
27481424
49.

Letter: avoiding misconceptions about elimination diet for eosinophilic oesophagitis.

Molina-Infante J, Lucendo AJ.

Aliment Pharmacol Ther. 2016 Jul;44(1):98-100. doi: 10.1111/apt.13639. No abstract available.

50.

Letter: Helicobacter pylori infection and eosinophilic oesophagitis - causal or casual inverse association?

Molina-Infante J, Lucendo AJ, Gisbert JP.

Aliment Pharmacol Ther. 2016 Jun;43(11):1244. doi: 10.1111/apt.13597. No abstract available.

Supplemental Content

Loading ...
Support Center